Matches in Nanopublications for { ?s ?p "[H(2)O(2) treatment of SCLC cells (over 15 min) led to phosphorylation of c-Met receptor tyrosine kinase and further upregulated downstream phosphorylation of phospho-AKT, ERK1/2, and paxillin in a dose-dependent manner (125 microM to 500 microM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP232326.RAclpVhl1OjgAwm0xVje-W9ddXeA3mtyStwk5Q6SNlsUY130_assertion description "[H(2)O(2) treatment of SCLC cells (over 15 min) led to phosphorylation of c-Met receptor tyrosine kinase and further upregulated downstream phosphorylation of phospho-AKT, ERK1/2, and paxillin in a dose-dependent manner (125 microM to 500 microM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232326.RAclpVhl1OjgAwm0xVje-W9ddXeA3mtyStwk5Q6SNlsUY130_provenance.
- NP554152.RAvzf6MbDcZVy2WA62CXDhoAheDqQUKkdsYYtlOkgc4-I130_assertion description "[H(2)O(2) treatment of SCLC cells (over 15 min) led to phosphorylation of c-Met receptor tyrosine kinase and further upregulated downstream phosphorylation of phospho-AKT, ERK1/2, and paxillin in a dose-dependent manner (125 microM to 500 microM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554152.RAvzf6MbDcZVy2WA62CXDhoAheDqQUKkdsYYtlOkgc4-I130_provenance.
- NP595817.RAg14RMXxfgtvbIj8EoadvTrUF2KcIasVZ_Df56r8AJl8130_assertion description "[H(2)O(2) treatment of SCLC cells (over 15 min) led to phosphorylation of c-Met receptor tyrosine kinase and further upregulated downstream phosphorylation of phospho-AKT, ERK1/2, and paxillin in a dose-dependent manner (125 microM to 500 microM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595817.RAg14RMXxfgtvbIj8EoadvTrUF2KcIasVZ_Df56r8AJl8130_provenance.
- NP595816.RAHrddT5JNxxwTVQlvAkD4MKVUAoCxsP4J5FdQ3slnmE0130_assertion description "[H(2)O(2) treatment of SCLC cells (over 15 min) led to phosphorylation of c-Met receptor tyrosine kinase and further upregulated downstream phosphorylation of phospho-AKT, ERK1/2, and paxillin in a dose-dependent manner (125 microM to 500 microM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595816.RAHrddT5JNxxwTVQlvAkD4MKVUAoCxsP4J5FdQ3slnmE0130_provenance.